DA-5221_01-R1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DA-5221_01-R1, covering 2024-09-27 to 2024-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers [Phase 1]